Related references
Note: Only part of the references are listed.Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis
Ahmad Hassan Ali et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)
A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis
Dennis D. Black et al.
HEPATOLOGY COMMUNICATIONS (2019)
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis
Mark R. Deneau et al.
HEPATOLOGY COMMUNICATIONS (2018)
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
Martin Kummen et al.
GUT (2017)
The Natural History of Primary Sclerosing Cholangitis in 781 Children: AMulticenter, International Collaboration
Mark R. Deneau et al.
HEPATOLOGY (2017)
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Peter Fickert et al.
JOURNAL OF HEPATOLOGY (2017)
Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis
James H. Tabibian et al.
AMERICAN JOURNAL OF THERAPEUTICS (2017)
Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
D. Kevans et al.
JOURNAL OF CROHNS & COLITIS (2016)
A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study
Shahab Rahimpour et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2016)
The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II
Noortje G. Rossen et al.
JOURNAL OF CROHNS & COLITIS (2015)
Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study
J. H. Tabibian et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Validation and Modification of Simplified Diagnostic Criteria for Autoimmune Hepatitis in Children
Elizabeth Mileti et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience
Michael H. Chapman et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes
Simon Hohenester et al.
HEPATOLOGY (2012)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Assessing Disease Activity in Ulcerative Colitis: Patients or Their Physicians?
Dan Turner et al.
INFLAMMATORY BOWEL DISEASES (2010)
Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study
Marina G. Silveira et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
Keith D. Lindor et al.
HEPATOLOGY (2009)
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
Susan N. Cullen et al.
JOURNAL OF HEPATOLOGY (2008)
Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: An immunomodulating antibiotic
Yinka K. Davies et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
High-dose ursodeoxycholic acid in primary sclerosing cholangitis:: A 5-year multicenter, randomized, controlled study
R Olsson et al.
GASTROENTEROLOGY (2005)
Regression to the mean: treatment effect without the intervention
V Morton et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2005)
Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial
M Färkkilä et al.
HEPATOLOGY (2004)
Share Paper
